By contrast, it is reported that STK39 was overexpressed in renal cell carcinoma [9], osteosarcoma [8] and breast cancer cells [18], while the knockdown of STK39 inhibited proliferation, metastasis and EMT of these cancer cells. Here, STK39 is linked to hereditary clear cell renal cell carcinoma.